2nd Quarter - Termination
BGR GOVERNMENT AFFAIRS for NEKTAR THERAPEUTICS
Client
Income
—
Expenses
—
Terminated
Apr 7, 2022
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and Nektar Therapeutics specifically.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL D. BAILEY | See prior filing |
| BRENT ALAN DEL MONTE | See prior filing |
| DANIEL FARMER | See prior filing |
| REMY LEIGH BRIM MASON | See prior filing |
| JOHN STONE | See prior filing |
| ROBB WALTON | See prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.